Table 2 Biomarker levels according to asbestos-related diseases (ARDs)
From: ATG5 as biomarker for early detection of malignant mesothelioma
| Â | non-ARDs | ARDs | p-value |
|---|---|---|---|
ATG5 (ng/ml) | 17.4 [11.9–23.3] | 18.6 [12.6–34.2] | 0.030 |
HMGB1 (ng/ml) | 11.1 [3.9–32.5] | 11.0 [7.3–20.7] | 0.470 |
miR-126 (Rel Exp) | 12.8 [0.04–98.2] | 9.5 [0.08–60.9] | 0.300 |
miR-222 (Rel Exp) | 0.65 [0.01–6.3] | 2.1 [0.002–33.1] | 0.033 |
Mesothelin (nM) | 0.3 [0.1–1.6] | 1.1 [0.001-32.0] | 0.050 |